ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
126 hedge funds and large institutions have $676M invested in Adamas Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 118 → 126 (+8)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
126
Holding in Top 10
4
Calls
$8.34M
Puts
$6.37M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$9.33M | |
| 3 | +$7.28M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.9M |
| 5 |
Millennium Management
New York
|
+$6.73M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$8.77M | |
| 3 | -$6.78M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.96M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.15M |